You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : RETAILING
  3. INDUSTRY : SPECIALTY RETAIL
  4. KENVUE INC

Kenvue Inc XNYS: KVUE

Kenvue Inc Live Share Price Today, Share Analysis and Chart

Expensive Performer
Download real time

23.31 -0.08 (-0.34%)

Near 52W High of $24.46

35.2M XNYS Volume

High volume today

XNYS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share

Kenvue Inc Key Metrics

Select

Market Capitalization

High in industry
44,551

PE TTM

High in industry
43.3

PEG TTM

Negative PEG TTM
-1.1

Price to Book

Below industry Median
4.6

Institutional holding current Qtr %

Below industry Median
101.4

Revenue Growth Qtr YoY %

Negative Revenue Growth Qtr YoY %
-0.1

Operating Revenue growth TTM %

Below industry Median
0.1

Net Profit Qtr Growth YoY %

Negative Net Profit Qtr Growth YoY %
-10.4

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
-38.1

Operating Profit Margin Qtr %

High in industry
15.2

Operating Profit Margin TTM %

High in industry
17

Piotroski Score

High in industry
6

Rel Perf vs Sector quarter%

10.4

ROE Annual %

Below industry Median
9.9

RoA Annual %

Below industry Median
3.9
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Expensive Valuation
9.8 / 100
Momentum Score
Technically Neutral
56.4 / 100
Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
24
1Yr Price target upside is 3%
15 analysts

12

S

13

W

4

O

0

T

SWOT Analysis

Kenvue Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '23Dec '24Dec '25Dec '2615k16k17kActual RevenueAvg. Estimate
Miss

Kenvue Inc's Revenue was lower than average estimate 2 times in past 2 years

EPS forecast

Current EPS
0.5
Avg. Estimate
1
Low Estimate
0.8
High Estimate
1.1
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 79.6% in FY25

Consensus Recommendation

17 ANALYST Recommendations
HOLD

Created with Highcharts 7.2.212Hold2Buy3Strong Buy

The consensus recommendation from 17 analysts for Kenvue Inc is HOLD

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Kenvue Inc Stock Analysis

Kenvue Inc stock analysis with key metrics, changes, and trends.

Kenvue Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$15,455 M0.07%positive

Annual Revenue rose 0.07%, in the last year to $15,455 M. Its sector's average revenue growth for the last fiscal year was 3.59%.

Annual Net Profit$1,030 M38.1%negative

Annual Net Profit fell 38.1% in the last year to $1,030 M. Its sector's average net profit growth for the last fiscal year was -37.43%.

Price to Earning Ratio43.25-negative

Price to Earning Ratio is 43.25, higher than its sector PE ratio of 33.73.

Stock Price$23.3112.55%negative

Stock Price rose 12.55% and underperformed its sector by 8.55% in the past year.

Quarterly Revenue$3,662 M0.11%negative

Quarterly Revenue fell 0.11% YoY to $3,662 M. Its sector's average revenue growth YoY for the quarter was 14.84%.

Quarterly Net profit$293 M10.4%negative

Quarterly Net profit fell 10.4% YoY to $293 M. Its sector's average net profit growth YoY for the quarter was 19.58%.

Debt to Equity Ratio0.9-positive

Debt to Equity Ratio of 0.9 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)9.87 %9.87%negative

Return on Equity(ROE) for the last financial year was 9.87%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding84.97 %0.31%positive

Mutual Fund Holding increased by 0.31% in the last quarter to 84.97.

Interest Coverage Ratio4.28-positive

Interest Coverage Ratio is 4.28, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding101.44 %0%neutral

Institutional Holding remained the same in the last quarter at 101.44%.

VIEW LESS


Loading data..

Kenvue Inc - Company Profile

What does Kenvue Inc do?

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Kenvue Inc Management structure

All Gross Remunerations are in USD
Mr. Thibaut Mongon
Chief Executive Officer and Director
-
2024
Gross Remuneration
Year
Ms. Heather Howlett
Chief Accounting Officer
-
2024
Gross Remuneration
Year
Mr. Paul Ruh
Chief Financial Officer
-
2024
Gross Remuneration
Year

Kenvue Inc Board of directors

All Gross Remunerations are in USD
Mr. Jeffrey C. Smith
Independent Director
-
2025
Gross Remuneration
Year
Ms. Erica L. Mann
Independent Director
-
2025
Gross Remuneration
Year
Ms. Sarah Hofstetter
Independent Director
-
2025
Gross Remuneration
Year

Kenvue Inc FAQ

How is Kenvue Inc today?
Kenvue Inc today is trading in the red, and is down by -0.34% at 23.31.
Kenvue Inc is currently trading down -0.34% on an intraday basis. In the past week the stock rose 2.19%. stock has been up 7.07% in the past quarter and rose 12.55% in the past year. You can view this in the overview section.